To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Researchers from the Karolinska Institutet in Sweden have found a potential new treatment for non-alcoholic fatty liver ...

Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...

Doctors can accurately predict a person's risk of fatty liver disease as early as 16 years before symptoms develop, a new ...